SCHEMBL20925355

SCHEMBL20925355

OC[C@H]1O[C@@H](n2ccc3c(Nc4ccc(OC(F)(F)F)cc4)ncnc32)C(O)[C@@H]1O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 2/20 0.73
▸ ADORA1 P30542 1/20 0.57
▸ ABL1 P00519 2/20 0.57
▸ BCR P11274 2/20 0.57
▸ METTL3 Q86U44 1/20 0.54
▸ METTL14 Q9HCE5 1/20 0.54
▸ SLC29A1 Q99808 3/20 0.53
▸ LMNA P02545 2/20 0.52
▸ ALDH1A1 P00352 1/20 0.52
▸ GLA P06280 1/20 0.52
▸ PMP22 Q01453 1/20 0.52
▸ SMN1; SMN2 Q16637 1/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ NPY1R P25929 1/20 0.52
▸ HTT P42858 1/20 0.52
▸ NPY2R P49146 1/20 0.52
▸ RAB9A P51151 1/20 0.52
▸ RXFP1 Q9HBX9 1/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ TSHR P16473 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16609159 1.00 ADK (0.73) ADKADORA1ABL1BCRMETTL3
SCHEMBL3397073 1.00 ADK (0.73) ADKADORA1ABL1BCRMETTL3
SCHEMBL13821121 1.00 ADK (0.73) ADKADORA1ABL1BCRMETTL3
SCHEMBL19681258 1.00 ADK (0.73) ADKADORA1ABL1BCRMETTL3
SCHEMBL24390241 0.85 ADORA1 (0.78) ADORA1SLC29A1LMNAALDH1A1GLA
SCHEMBL16609165 0.85 ADORA1 (0.78) ADORA1SLC29A1LMNAALDH1A1GLA
SCHEMBL13820258 0.85 ADORA1 (0.78) ADORA1SLC29A1LMNAALDH1A1GLA
SCHEMBL3395259 0.85 ADORA1 (0.78) ADORA1SLC29A1LMNAALDH1A1GLA
SCHEMBL16363330 0.85 ADK (0.81) ADKADORA1METTL3METTL14SLC29A1
SCHEMBL16605527 0.85 ADK (0.81) ADKADORA1METTL3METTL14SLC29A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3150593-B1 SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND METHODS OF USE DANA FARBER CANCER INST INC (US) 2019-04-24 — — EP disclosed
Send feedback